March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Heating Wet Chamber Goggles (Blephasteam®) In Meibomian Gland Dysfunction Unresponsive To Warm Compress Treatment
Author Affiliations & Notes
  • Edoardo Villani
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Fabrizio Magnani
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Veronica Canton
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Elena Garoli
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Francesco Viola
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Roberto Ratiglia
    UO Oculistica, Univ of Milan Fnd IRCCS Ca' Granda OMP, Milan, Italy
  • Footnotes
    Commercial Relationships  Edoardo Villani, Laboratoires Thea, Clermont-Ferrand, France (F, R); Fabrizio Magnani, None; Veronica Canton, None; Elena Garoli, None; Francesco Viola, None; Roberto Ratiglia, Laboratoires Thea, Clermont-Ferrand, France (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 602. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Edoardo Villani, Fabrizio Magnani, Veronica Canton, Elena Garoli, Francesco Viola, Roberto Ratiglia; Heating Wet Chamber Goggles (Blephasteam®) In Meibomian Gland Dysfunction Unresponsive To Warm Compress Treatment. Invest. Ophthalmol. Vis. Sci. 2012;53(14):602.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the safety and efficacy of wet chamber warming goggles (Blephasteam®) in patients with meibomian gland dysfunction (MGD) unresponsive to warm compress treatment.

Methods: : We consecutively enrolled 15 adult patients with low-delivery, non-cicatricial, MGD unresponsive to warm compress treatment. We considered unresponsive the patients who showed no OSDI or BUT improvement after 3 weeks of treatment with warm compresses used twice a day during 10 minutes. The patients were instructed to use Blephasteam® (Laboratoires Thea, Clermont-Ferrand, France) twice a day during 10 minutes, with a following lid massage. Outcome measures were assessed in the worst eye (lower BUT) at baseline and after 3 weeks, including OSDI score, BUT, corneal fluorescein staining, MGs expressibility, Schirmer test. In vivo laser scanning confocal microscopy (LSCM) was used to study MGs in the lower eyelid, quantifying the mean acinar units diameter (manually measured as the longest axis of the acinar unit), acinar units area (calculated automatically after manual demarcation of the boundary), density of MGs (manually marked inside each 400x400 µm frame and calculated automatically with the Cell Count software, Heidelberg Engineering GmbH, Dortmund, Germany), diameter of glandular orifices (manually marked as the longest axis of orifice); meibum secretion reflectivity; inhomogeneous appearance of interstice and wall of acinar units.

Results: : After 3 weeks of treatment, mean OSDI score decreased from 37.7±17.5 to 23.2±12.4 and mean BUT decreased from 6.0±2.5 to 8.4±2.0 (P<0.05, paired samples T-test). LSCM showed decrease of mean acinar diameter (from 105.3±19.5 to 88.2±23.6; P<0.05) and area (from 8912±2205 to 6876±1418; P<0.05).

Conclusions: : Eyelid warming is the mainstay of the clinical treatment of MGD and its poor results may be often due to lack of compliance and standardization. Blephasteam® wet chamber warming goggles are a promising alternative to classical warm compress treatment, potentially able to improve the weaknesses of the "warming approach".

Keywords: cornea: tears/tear film/dry eye • cornea: clinical science • imaging/image analysis: clinical 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×